PL1867322T3 - Kompozycja do zastosowania miejscowego w leczeniu łuszczycy - Google Patents
Kompozycja do zastosowania miejscowego w leczeniu łuszczycyInfo
- Publication number
- PL1867322T3 PL1867322T3 PL07380166T PL07380166T PL1867322T3 PL 1867322 T3 PL1867322 T3 PL 1867322T3 PL 07380166 T PL07380166 T PL 07380166T PL 07380166 T PL07380166 T PL 07380166T PL 1867322 T3 PL1867322 T3 PL 1867322T3
- Authority
- PL
- Poland
- Prior art keywords
- psoriasis
- treatment
- topical composition
- moisturising
- keratolytic
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title abstract 3
- 230000000699 topical effect Effects 0.000 title abstract 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 abstract 1
- 229940124091 Keratolytic Drugs 0.000 abstract 1
- 244000050054 Rosa moschata Species 0.000 abstract 1
- 235000000657 Rosa moschata Nutrition 0.000 abstract 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 abstract 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000002421 anti-septic effect Effects 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 229960001102 betamethasone dipropionate Drugs 0.000 abstract 1
- CIWBQSYVNNPZIQ-XYWKZLDCSA-N betamethasone dipropionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CIWBQSYVNNPZIQ-XYWKZLDCSA-N 0.000 abstract 1
- 239000004202 carbamide Substances 0.000 abstract 1
- 239000003974 emollient agent Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000001530 keratinolytic effect Effects 0.000 abstract 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001172 regenerating effect Effects 0.000 abstract 1
- 239000010666 rose oil Substances 0.000 abstract 1
- 229960004889 salicylic acid Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 239000003871 white petrolatum Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200601574A ES2288133B1 (es) | 2006-06-12 | 2006-06-12 | Composicion topica para el tratamiento de la psoriasis. |
EP07380166A EP1867322B1 (en) | 2006-06-12 | 2007-06-11 | Topical composition for the treatment of psoriasis |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1867322T3 true PL1867322T3 (pl) | 2010-06-30 |
Family
ID=38457686
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07380166T PL1867322T3 (pl) | 2006-06-12 | 2007-06-11 | Kompozycja do zastosowania miejscowego w leczeniu łuszczycy |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1867322B1 (pl) |
AT (1) | ATE455536T1 (pl) |
DE (1) | DE602007004381D1 (pl) |
ES (1) | ES2288133B1 (pl) |
PL (1) | PL1867322T3 (pl) |
PT (1) | PT1867322E (pl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2244709A4 (en) * | 2008-02-07 | 2012-02-29 | Synta Pharmaceuticals Corp | TOPICAL FORMULATIONS FOR THE TREATMENT OF PSORIASIS |
US20090258098A1 (en) * | 2008-04-15 | 2009-10-15 | Lane Rolling | Penetrating carrier, antifungal composition using the same and method for treatment of dermatophyte infections |
ES2362066B1 (es) * | 2009-11-23 | 2012-05-25 | Juan Barroso Abril | Preparación combinada para el tratamiento de la psoriasis. |
RU2489144C2 (ru) * | 2011-06-07 | 2013-08-10 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО АКРИХИН") | Фармацевтическая композиция для лечения заболеваний кожи и способ ее получения |
CN102652772B (zh) * | 2012-05-15 | 2013-09-11 | 牛丽丽 | 一种治疗银屑病及神经性皮炎的中草药丸 |
ES2562085B1 (es) * | 2014-09-02 | 2016-07-07 | Amedyn Healthcare, S.L. | Crema para el tratamiento de pieles con estados descamativos y procedimiento de fabricación de dicha crema |
CN113318069A (zh) * | 2021-05-18 | 2021-08-31 | 南方医科大学皮肤病医院 | 一种用于治疗银屑病的抗炎外用乳膏及其制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4740372A (en) * | 1986-09-17 | 1988-04-26 | Ljubomir Boncic | Composition for treating psoriasis vulgaris and a method for its preparation |
EP0717994A1 (en) * | 1994-07-07 | 1996-06-26 | Ignacio Anton Lujambio Galdeano | New formulation for the topical treatment of psoriasis |
ES2083333B1 (es) * | 1994-09-22 | 1997-01-16 | Corral Begona Gozalo | Crema para el tratamiento de la psoriasis. |
IT1320192B1 (it) * | 2000-05-12 | 2003-11-26 | Giovanni Summo | Composizione terapeutica per la cura della psoriasi. |
ES2188426B1 (es) | 2001-12-12 | 2004-11-16 | Rosalia Pidal Fernandez | Composicion farmaceutica para el tratamiento de la psoriasis y otras dermopatias. |
RO120529B1 (ro) | 2002-05-13 | 2006-03-30 | Institutul De Tehnologie Chimică - Itec S.A. | Compoziţie antioxidantă pe bază de extracte naturale, pentru tratarea psoriazisului |
BG65352B1 (bg) * | 2002-05-16 | 2008-03-31 | "Софарма" Ад | Средство за лечение на псориазис |
ES2231007B2 (es) * | 2003-10-13 | 2006-09-16 | Alfredo Garcia Beltran | Crema para el tratamiento de la psoriasis. |
SE0402029D0 (sv) | 2004-08-17 | 2004-08-17 | Synphora Ab | Prostaglandin a derivatieves for the treatment of psoriasis |
US20060078580A1 (en) * | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
EP1863434A4 (en) * | 2005-03-16 | 2012-03-07 | Taro Pharmaceuticals Usa Inc | STABLE AQUEOUS EMULSION FORMULATION COMPRISING UREA AND SALICYLIC ACID AND METHOD OF USE |
-
2006
- 2006-06-12 ES ES200601574A patent/ES2288133B1/es active Active
-
2007
- 2007-06-11 AT AT07380166T patent/ATE455536T1/de not_active IP Right Cessation
- 2007-06-11 EP EP07380166A patent/EP1867322B1/en not_active Not-in-force
- 2007-06-11 PT PT07380166T patent/PT1867322E/pt unknown
- 2007-06-11 DE DE602007004381T patent/DE602007004381D1/de active Active
- 2007-06-11 PL PL07380166T patent/PL1867322T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
PT1867322E (pt) | 2010-04-07 |
EP1867322B1 (en) | 2010-01-20 |
EP1867322A1 (en) | 2007-12-19 |
DE602007004381D1 (de) | 2010-03-11 |
ATE455536T1 (de) | 2010-02-15 |
ES2288133A1 (es) | 2007-12-16 |
ES2288133B1 (es) | 2008-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1867322T3 (pl) | Kompozycja do zastosowania miejscowego w leczeniu łuszczycy | |
ES2348278T3 (es) | Composiciones cosméticas y dermofarmacéuticas para las pieles con tendencia acnéica. | |
ATE412417T1 (de) | Topische zusammensetzung zur behandlung von psoriasis und verwandten hautkrankheiten | |
ATE361084T1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
CA2191129A1 (fr) | Medicaments a base de metronidazole ou d'un melange synergetique de metronidazole et de clindamycine | |
US6911196B2 (en) | Topical medicament for treating nappy rash | |
BRPI0414800A (pt) | composições de higiene oral baseadas em morinda citrifolia e seus usos | |
RU2007101538A (ru) | Применение фармацевтической композиции, содержащей кальцитриол и пропионат клобетазола, для лечения псориаза | |
DE69832710D1 (de) | Nicht-irritierende zusammensetzung zur behandlung des aknes und andere hautzustände | |
US20060159714A1 (en) | Use of an antioxidant in a dermatological and/or cosmetic composition | |
US5843998A (en) | Skin blemish treatment | |
ATE414526T1 (de) | Zubereitungen zur behandlung von arthritischen erscheinungen | |
CY1109507T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα ελαστομερες οργανοπολυσιλοξανιο και μια διαλυτοποιημενη δραστικη ουσια | |
DK284386D0 (da) | Farmaceutisk praeparat mod hudlidelser | |
GT199900081A (es) | Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos. | |
ES2573478T3 (es) | Utilización de composiciones que comprenden por lo menos un lignano y/o neolignano para modular la tasa de testosterona | |
BRPI0417116A (pt) | usos de uma quantidade eficaz de ondansetron e composição para tratamento tópico de uma inflamação | |
DE60316724D1 (de) | Pharmazeutische zusammensetzung enthaltend calcitriol und clobetasol propionate | |
MXPA06002624A (es) | Uso topico de derivados de acido halosalisilico. | |
DE602004031964D1 (de) | Ndlung von dermatologischen erkrankungen | |
US20140127315A1 (en) | Caudal Salve | |
BR0014117A (pt) | Uso de sabÈes de acido graxo/aminoácido para aumentar a eficácia antimicrobiana de composições farmacêutica tópicas | |
AR025602A1 (es) | Composiciones farmaceuticas y/o cosmeticas | |
UA137068U (uk) | Фармацевтична композиція у формі мазі для лікування дерматозів з порушенням кератинізації | |
RU2002119623A (ru) | Противовоспалительный и антиаллергический состав |